On May 3, 2023 Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, reported it will present its first quarter 2023 financial results and provide a corporate update following market close on Thursday, May 11, 2023 (Press release, Gritstone Bio, MAY 3, 2023, View Source [SID1234630917]). The announcement will be followed by a conference call and audio webcast, which will begin at 4:30pm ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Live Conference Call & Webcast
Toll Free: 1-888-999-6281
International: 1-848-280-6550
Conference ID: 1754341
Webcast: View Source;tp_key=c6c637ac24

While not required, it is recommended you join five minutes prior to the event’s start. An archived replay will be accessible at View Source for 30 days following the event.